Financial statements Subpharmex
Balance sheet data of SUBPHARMEX
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Total assets | 11 333,38 | 14 711,73 | 13 335,67 | 5 011,67 |
| A. Fixed assets | 0,00 | 1 000,00 | 1 000,00 | 1 000,00 |
| B. Current assets | 11 333,38 | 13 711,73 | 12 335,67 | 4 011,67 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 11 333,38 | 14 711,73 | 13 335,67 | 5 011,67 |
| A. Equity | 11 333,38 | -11 445,02 | -19 714,76 | -23 314,76 |
| B. Liabilities and provisions for liabilities | 0,00 | 26 156,75 | 33 050,43 | 28 326,43 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.